Home
>
National Drug Code (NDC)
>
Respaire-30
Respaire-30 - 16477-306-01 - (GUAIFENESIN)
Drug Information of Respaire-30
| Product NDC: | 16477-306 |
| Proprietary Name: | Respaire-30 |
| Non Proprietary Name: | GUAIFENESIN |
| Active Ingredient(s): | 150; 30 mg/1; mg/1 & nbsp; GUAIFENESIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Respaire-30
| Product NDC: | 16477-306 |
| Labeler Name: | Laser Pharmaceuticals, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20080902 |
Package Information of Respaire-30
| Package NDC: | 16477-306-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (16477-306-01) |
NDC Information of Respaire-30
| NDC Code | 16477-306-01 |
| Proprietary Name | Respaire-30 |
| Package Description | 100 CAPSULE in 1 BOTTLE (16477-306-01) |
| Product NDC | 16477-306 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | GUAIFENESIN |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20080902 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Laser Pharmaceuticals, LLC |
| Substance Name | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 150; 30 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |
